zinc finger protein 736 pseudogene 10, Y-linkedGenealiases: []
Q-omics provides the consensus-scored ZNF736P10Y profile across patient tissues and cancer cell-line models. ZNF736P10Y expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, ZNF736P10Y is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, ZNF736P10Y RNA expression shows 4,929 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UCS, THCA, and STAD as cancer lineages where ZNF736P10Y shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZNF736P10Y — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ZNF736P10Y survival associations across molecular data types. ZNF736P10Y RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZNF736P10Y RNA expression–survival associations across cancer types. High ZNF736P10Y expression shows unfavorable associations in UCS, OV, UVM, STAD, SKCM and ACC. The UCS Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for ZNF736P10Y RNA expression.
This table summarizes ZNF736P10Y tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for ZNF736P10Y. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ZNF736P10Y shows lower tumor expression in THCA. The THCA box plot shows higher ZNF736P10Y RNA expression in normal versus tumor tissue (log2 FC = −0.005, t-test p = .049).
This table shows molecular features associated with ZNF736P10Y in patient tissues and cancer cell lines. In patient samples, ZNF736P10Y shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
